Biodegradable Drug Eluting Stents Market: By Material, By Application, By End-User and Geography

Biodegradable Drug Eluting Stents Market Size, Share, Growth, Trends, and Global Industry Analysis: By Material ( Metallic Alloy Stents, Polymeric Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-User (Hospitals Cardiac Centers) and Region

Biodegradable Drug Eluting Stents Market size was valued at US$ 6.2 billion in 2023 and is poised to grow at a significant CAGR of 6.3% from 2024-2030. Drug-eluting stents are peripheral or coronary stents placed into narrowed peripheral or coronary arteries that slowly release the drug to block cell proliferation. Generally, these devices are made up of metal and remain permanently or removed through further surgery. Metal stents present drawbacks such as the predisposition to late stent thrombosis, impairment of imaging with multislice CT, hindrance of surgical revascularization. Biodegradable drug-eluting stents are made up of material that dissolves or absorbed in the body, these are temporary, and no need for further surgery to removal of the stent. These are also called as bioresorbable stents or naturally- dissolving stents.

Biodegradable Drug Eluting Stents Market Key Developments:

In October 2015, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the synergy bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
Risk of complications in use and lower awareness about biodegradable stents among healthcare professionals in developing and developed regions are expected to hamper the growth of Biodegradable Drug Eluting Stents Market over the forecast period.

Download Free Sample

Global Biodegradable Drug Eluting Stents Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.3%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Biodegradable Drug Eluting Stents Market Dynamics

Biodegradable Drug growth is driven by growing prevalence of coronary artery diseases, increased geriatric population who are more prone to heart diseases. According to World Health Organization (WHO), cardiovascular diseases are a primary cause of deaths globally, an estimated 17.7 Mn people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 Mn were due to coronary heart disease and 6.7 million were due to heart stroke. Furthermore, biodegradable drug-eluting stents have various advantages over the traditional metal stents such as no need of further surgery to remove stent, quick restoration of blood flow and faster healing process which are expected to boost the biodegradable drug eluting stents market.

North-America Got Significant Share

Biodegradable Drug Eluting Stents Market Regional Analysis

Geographically biodegradable drug eluting stents market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In North America, U.S. represents the largest market owing to the higher prevalence of cardiovascular diseases especially coronary artery diseases. Asia Pacific region is expected to register significant growth rate due to increasing awareness about biodegradable drug eluting stents in this region. In Asia region, India, China, Japan are expected to grow at significant rate owing to rise in prevalence of chronic diseases, such as diabetes and cardiac diseases which are expected to boost the demand for biodegradable drug eluting stents over the forecast period.

Latin America

Europe

Asia Pacific

Middle East

North America

Global Biodegradable Drug Eluting Stents Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market Size in 2023	US$ 6.2 billion
Market CAGR	6.3%
By Type of Material	Metallic Alloy Stents Polymeric Stents
By Application	Coronary Artery Disease Peripheral Artery Disease
By End-user	Hospitals Cardiac Centers
By Region	North America Latin America Europe Asia Pacific Middle East and Africa

Key Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The biodegradable drug eluting stents market size was valued at US$ 6.2 billion in 2023.

The key segments covered in the biodegradable drug eluting stents market are technology, components, application, and end-users.

The Biodegradable drug eluting stents market key players Biosensors International Group (Singapore), Abbott Laboratories (U.S), Medtronic (U.S.), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan)

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary

2.Global Biodegradable Drug Eluting Stents Market Introduction

2.1.Global Biodegradable Drug Eluting Stents Market - Taxonomy

2.2.Global Biodegradable Drug Eluting Stents Market - Definitions

2.2.1.Type of Material

2.2.2.Application

2.2.3.End-user

2.2.4.Region

3.Global Biodegradable Drug Eluting Stents Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Product Landscape

3.6. New Product Launches

3.7. Impact of COVID 19 on Market

4.Global Biodegradable Drug Eluting Stents Market Analysis, 2019 - 2023 and Forecast 2024 - 2030

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5.Global Biodegradable Drug Eluting Stents Market By Type of Material, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

5.1. Metallic Alloy Stents

5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Polymeric Stents

5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6.Global Biodegradable Drug Eluting Stents Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

6.1. Coronary Artery Disease

6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Peripheral Artery Disease

6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

7.Global Biodegradable Drug Eluting Stents Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

7.1. Hospitals

7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Cardiac Centers

7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

8.Global Biodegradable Drug Eluting Stents Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

8.1. North America

8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific (APAC)

8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Middle East and Africa (MEA)

8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Latin America

8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9.North America Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

9.1. Type of Material Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.1.1.Metallic Alloy Stents

9.1.2.Polymeric Stents

9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.2.1.Coronary Artery Disease

9.2.2.Peripheral Artery Disease

9.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.3.1.Hospitals

9.3.2.Cardiac Centers

9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.4.1.United States of America (USA)

9.4.2.Canada

10.Europe Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

10.1. Type of Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.1.1.Metallic Alloy Stents

10.1.2.Polymeric Stents

10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.2.1.Coronary Artery Disease

10.2.2.Peripheral Artery Disease

10.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.3.1.Hospitals

10.3.2.Cardiac Centers

10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.4.1.Germany

10.4.2.France

10.4.3.Italy

10.4.4.United Kingdom (UK)

10.4.5.Spain

10.4.6.Rest of EU

11.Asia Pacific (APAC) Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

11.1. Type of Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.1.1.Metallic Alloy Stents

11.1.2.Polymeric Stents

11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.2.1.Coronary Artery Disease

11.2.2.Peripheral Artery Disease

11.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.3.1.Hospitals

11.3.2.Cardiac Centers

11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.4.1.China

11.4.2.India

11.4.3.Australia and New Zealand (ANZ)

11.4.4.Japan

11.4.5.Rest of APAC

12.Middle East and Africa (MEA) Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

12.1. Type of Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.1.1.Metallic Alloy Stents

12.1.2.Polymeric Stents

12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.2.1.Coronary Artery Disease

12.2.2.Peripheral Artery Disease

12.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.3.1.Hospitals

12.3.2.Cardiac Centers

12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.4.1.GCC Countries

12.4.2.South Africa

12.4.3.Rest of MEA

13.Latin America Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

13.1. Type of Material Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.1.1.Metallic Alloy Stents

13.1.2.Polymeric Stents

13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.2.1.Coronary Artery Disease

13.2.2.Peripheral Artery Disease

13.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.3.1.Hospitals

13.3.2.Cardiac Centers

13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.4.1.Brazil

13.4.2.Mexico

13.4.3.Rest of LA

14. Competition Landscape

14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)

14.2.1.Biosensors International Group (Singapore)

14.2.2.Abbott Laboratories (U.S)

14.2.3.Medtronic (U.S.)

14.2.4.B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany)

14.2.5.Boston Scientific Corporation (U.S.)

14.2.6.Terumo Corporation (Japan)

15. Research Methodology

16. Appendix and Abbreviations

Key Market Players

Biosensors International Group (Singapore
Abbott Laboratories
Medtronic
B. Braun Holding GmbH & Co. KG (B.Braun Melsungen)
Boston Scientific Corporation
Terumo Corporation

Related Industry Reports

Light Therapy Market

Lithuania Peripheral Vascular Market

Ligase Market

Greece Endoscopy Market